Cite
HARVARD Citation
Lindström, L. et al. (n.d.). 1812 Intra-tumor heterogeneity of the estrogen receptor predicts less benefit from tamoxifen therapy and poor long-term breast cancer patient survival. Retrospective analyses of the STO3 randomizedtrial. European journal of cancer. pp. S269-. [Online].